Showing results (11-20 of 236) with videos related to

Sort By:
Pageof 24
Scandinavian Journal of Gastroenterology|June 21, 2016
MELD score measured day 10 after orthotopic liver transplantation predicts death and re-transplantation within the first yearAndreas A Rostved, Jens D Lundgren, Jens Hillingsø, et al.
Central European Journal of Public Health|October 22, 2008
The EuroSIDA study: Regional differences in the HIV-1 epidemic and treatment response to antiretroviral therapy among HIV-infected patients across Europe--a review of published resultsDaria Podlekareva, Wendy Bannister, Amanda Mocroft, et al.
AIDS (London, England)|March 29, 2002
Highly active antiretroviral therapy and cervical intraepithelial neoplasiaAntonia L Moore, Caroline A Sabin, Sara Madge, et al.
AIDS (London, England)|February 24, 2010
Risk of all-cause mortality associated with nonfatal AIDS and serious non-AIDS events among adults infected with HIVJacqueline Neuhaus, Brian Angus, Justyna D Kowalska, et al.
International Journal of Cancer|March 7, 2019
Development and validation of a cycle-specific risk score for febrile neutropenia during chemotherapy cycles 2-6 in patients with solid cancers: The <sup>CSR</sup> FENCE scoreTheis Aagaard, Joanne Reekie, Ashley Roen, et al.
AIDS (London, England)|December 4, 2004
Causes of death in HIV infection: the key determinant to define the clinical response to anti-HIV therapyAmanda Mocroft, Jose Gatell, Peter Reiss, et al.
HIV Medicine|September 1, 2021
Improving healthcare for patients with HIV, tuberculosis and hepatitis C in eastern Europe: a review of current challenges and important next stepsChristian Kraef, Adrian Bentzon, Alena Skrahina, et al.
Antiviral Therapy|February 22, 2007
HIV-1 subtypes and response to combination antiretroviral therapy in EuropeWendy P Bannister, Lidia Ruiz, Clive Loveday, et al.
Cancer Medicine|March 8, 2020
Mortality and admission to intensive care units after febrile neutropenia in patients with cancerTheis Aagaard, Joanne Reekie, Mette Jørgensen, et al.
Open Forum Infectious Diseases|June 19, 2019
Risk Factors for Failure of Primary (Val)ganciclovir Prophylaxis Against Cytomegalovirus Infection and Disease in Solid Organ Transplant RecipientsMark P Khurana, Isabelle P Lodding, Amanda Mocroft, et al.
Pageof 24